Integral Diagnostics Limited (IDX.AX)

AUD 2.17

(1.4%)

Net Debt Summary of Integral Diagnostics Limited

Integral Diagnostics Limited's latest annual net debt in 2024 was 315.35 Million AUD , down -4.79% from previous year.
Integral Diagnostics Limited's latest quarterly net debt in 2024 FY was 315.35 Million AUD , down -4.79% from previous quarter.
Integral Diagnostics Limited reported annual net debt of 331.22 Million AUD in 2023, up 52.08% from previous year.
Integral Diagnostics Limited reported annual net debt of 217.79 Million AUD in 2022, down -11.52% from previous year.
Integral Diagnostics Limited reported quarterly net debt of 343.5 Million AUD for 2024 Q2, up 3.71% from previous quarter.
Integral Diagnostics Limited reported quarterly net debt of 315.35 Million AUD for 2024 Q4, down -8.19% from previous quarter.

Annual Net Debt Chart of Integral Diagnostics Limited (2024 - 2013)

Historical Annual Net Debt of Integral Diagnostics Limited (2024 - 2013)

Year	Net Debt	Net Debt Growth
2024	315.35 Million AUD	-4.79%
2023	331.22 Million AUD	52.08%
2022	217.79 Million AUD	-11.52%
2021	246.15 Million AUD	11.95%
2020	219.88 Million AUD	86.21%
2019	118.08 Million AUD	165.48%
2018	44.47 Million AUD	-8.63%
2017	48.68 Million AUD	8.37%
2016	44.92 Million AUD	-10.51%
2015	50.2 Million AUD	1122.09%
2014	4.1 Million AUD	46259.47%
2013	-8899.00 AUD	0.0%

Year	Net Debt	Net Debt Growth
2024 FY	315.35 Million AUD	-4.79%
2024 Q2	343.5 Million AUD	3.71%
2024 Q4	315.35 Million AUD	-8.19%
2023 Q2	327.97 Million AUD	50.59%
2023 FY	331.22 Million AUD	52.08%
2023 Q4	331.22 Million AUD	0.99%
2022 FY	217.79 Million AUD	-11.52%
2022 Q2	294.79 Million AUD	19.76%
2022 Q4	217.79 Million AUD	-26.12%
2021 Q2	241.02 Million AUD	9.61%
2021 Q4	246.15 Million AUD	2.13%
2021 FY	246.15 Million AUD	11.95%
2020 Q4	219.88 Million AUD	-3.82%
2020 FY	219.88 Million AUD	86.21%
2020 Q2	228.61 Million AUD	93.61%
2019 Q2	104.77 Million AUD	135.57%
2019 Q4	118.08 Million AUD	12.7%
2019 FY	118.08 Million AUD	165.48%
2018 Q2	31.14 Million AUD	-36.02%
2018 FY	44.47 Million AUD	-8.63%
2018 Q4	44.47 Million AUD	42.81%
2017 Q2	50.79 Million AUD	13.06%
2017 Q4	48.68 Million AUD	-4.15%
2017 FY	48.68 Million AUD	8.37%
2016 Q4	44.92 Million AUD	1.29%
2016 Q2	44.35 Million AUD	-33.79%
2016 FY	44.92 Million AUD	-10.51%
2015 Q4	66.98 Million AUD	0.0%
2015 FY	50.2 Million AUD	1122.09%
2014 FY	4.1 Million AUD	46259.47%
2013 FY	-8899.00 AUD	0.0%

Peer Net Debt Comparison of Integral Diagnostics Limited

Name	Net Debt	Net Debt Difference
Australian Clinical Labs Limited	282.76 Million AUD	-11.528%
BCAL Diagnostics Limited	-5.83 Million AUD	5507.717%
Genetic Signatures Limited	-35.03 Million AUD	1000.228%
Genetic Technologies Limited	-377.06 Thousand AUD	83735.848%
Healius Limited	1.53 Billion AUD	79.493%
Imagion Biosystems Limited	5.81 Million AUD	-5326.687%
INOVIQ Ltd	-8.69 Million AUD	3725.594%
Microba Life Sciences Limited	-20.49 Million AUD	1638.782%
Monash IVF Group Limited	48.23 Million AUD	-553.838%
Rhythm Biosciences Limited	-545.67 Thousand AUD	57892.565%
Sonic Healthcare Limited	3.87 Billion AUD	91.852%